A new AI-driven imaging platform enables precise drug delivery to targeted areas of the lung, enhancing treatment for lung diseases. It also offers valuable insights into lung biology, improving the effectiveness of inhalation therapies.
A team led by Prof. Dr. Jens Vogel-Claussen and Dr. Andreas Voskrebenzev from the DZL site BREATH has developed an innovative MRI method that provides a regional view of lung function without radiation exposure or...
An ATS workshop led by DZL scientist Prof. Mareike Lehmann brings together leading experts to advance precision-cut lung slices (PCLS) as a promising tool for the development of targeted therapies.
Still, about 45,000 Germans die annually from lung cancer due to late detection. This is set to change now. Scientists, with DZL involvement, have outlined the key points of a national early detection program that...
An imaging technique developed by DZL researchers can predict chronic rejection reactions that occur years after transplantation.
Successful collaboration of scientists from the German Centers for Lung Research (DZL), Infection Research (DZIF) and Cardiovascular Research (DZHK) elucidates mechanism of brain damage in SARS-CoV-2 infection.
The DZL Annual Report 2020 has been published in German and English and is now available from the Media Center.
The still relatively young field of single cell analysis has virtually transformed our understanding of the cellular mechanisms of diseases.
Is computed tomography suitable for detecting lung cancer at a very early stage and thus still well treatable? Scientists at the German Cancer Research Center have investigated this with the LUSI study started in 2007.
The new technology can be used to understand the therapeutic success of inhaled active substances.
DZL Principal Investigator Jens Vogel-Claussen receives Wilhelm-Conrad-Röntgen-Ring
TLRC Researcher, Dr. Mark Wielpütz, received an award for the Best Scientific Paper Presentation 2014 at the European Congress of Radiology (ERC) Meeting.
